<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Bjerrum | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/handbreak22/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/handbreak22/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bjerrum.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">80d295067d5da365236bda8f28f982d4</guid>
				<title>Bjerrum posted an update: ted by IM, but some between-group differences were [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42150/</link>
				<pubDate>Sat, 08 Feb 2025 12:33:22 -0800</pubDate>

									<content:encoded><![CDATA[<p>ted by IM, but some between-group differences were statistically significant, and it is possible that different factors predominated at different times after V2, creating a complex relationship with V2H duration. The optimum IM protocol will depend on local conditions and production objectives but, as a generalization and assuming ad libitum&hellip;<span class="activity-read-more" id="activity-read-more-42150"><a href="http://www.nationalboardinstitute.com/activity/p/42150/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">90e16ab9282860e81e67ddfbff580c33</guid>
				<title>Bjerrum posted an update: The aim of our study was to evaluate all-cause mortality [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40273/</link>
				<pubDate>Thu, 06 Feb 2025 15:13:00 -0800</pubDate>

									<content:encoded><![CDATA[<p>The aim of our study was to evaluate all-cause mortality risk in patients with laboratory-confirmed COVID-19 in Mexico City treated with repurposed antivirals and antibiotics. This real-world retrospective cohort study contemplated 395,343 patients evaluated for suspected COVID-19 between February 24 and September 14, 2020 in 688&hellip;<span class="activity-read-more" id="activity-read-more-40273"><a href="http://www.nationalboardinstitute.com/activity/p/40273/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">351e7c618cbb0353d046175f8fbd0117</guid>
				<title>Bjerrum posted an update: Despite the high number of researches on pancreatic [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30905/</link>
				<pubDate>Tue, 28 Jan 2025 15:54:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>Despite the high number of researches on pancreatic adenocarcinoma (PAAD) over past decades, little progress had been made due to lack of effective treatment regimens. We aimed to investigate the expression level, mutation, and clinical significance of the Frizzled (FZD) family in PAAD so as to establish a sufficient scientific evidence for&hellip;<span class="activity-read-more" id="activity-read-more-30905"><a href="http://www.nationalboardinstitute.com/activity/p/30905/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f349f3bdb086e1075242871bbfa7a0a4</guid>
				<title>Bjerrum became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30864/</link>
				<pubDate>Tue, 28 Jan 2025 15:51:16 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>